Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics


Revance Therapeutics, Inc. (RVNC)

Today's Latest Price: $24.72 USD

0.62 (-2.45%)

Updated Jul 10 4:00pm

Add RVNC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

RVNC Stock Summary

  • With a price/sales ratio of 7,307.39, Revance Therapeutics Inc has a higher such ratio than 99.77% of stocks in our set.
  • With a year-over-year growth in debt of 533.83%, Revance Therapeutics Inc's debt growth rate surpasses 96.8% of about US stocks.
  • Revenue growth over the past 12 months for Revance Therapeutics Inc comes in at -94.94%, a number that bests only 0.86% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Revance Therapeutics Inc, a group of peers worth examining would be VNRX, TRVN, AUPH, PSTI, and CNCE.
  • RVNC's SEC filings can be seen here. And to visit Revance Therapeutics Inc's official web site, go to www.revance.com.
RVNC Daily Price Range
RVNC 52-Week Price Range

RVNC Stock Price Chart Technical Analysis Charts


RVNC Price/Volume Stats

Current price $24.72 52-week high $27.97
Prev. close $25.34 52-week low $9.88
Day low $24.42 Volume 653,791
Day high $25.74 Avg. volume 777,637
50-day MA $22.06 Dividend yield N/A
200-day MA $18.75 Market Cap 1.41B

Revance Therapeutics, Inc. (RVNC) Company Bio


Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company was founded in 1999 and is based in Newark, California.


RVNC Latest News Stream


Event/TimeNews Detail
Loading, please wait...

RVNC Latest Social Stream


Loading social stream, please wait...

View Full RVNC Social Stream

Latest RVNC News From Around the Web

Below are the latest news stories about Revance Therapeutics Inc that investors may wish to consider to help them evaluate RVNC as an investment opportunity.

Is Revance Therapeutics Inc (RVNC) Going to Burn These Hedge Funds?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]

Yahoo | July 5, 2020

Revance's DAXI shows positive effect in frown line studies

Revance Therapeutics (RVNC) announces positive results from two open-label dose-escalating Phase 2a clinical trials evaluating DaxibotulinumtoxinA ((DAXI)) for the treatment of dynamic forehead lines following glabellar (frown) line injections and lateral canthal lines (crow’s feet).Both showed that DAXI was efficacious while being well-tolerated.In the forehead lines study, 100% of participants...

Seeking Alpha | June 30, 2020

Revance Announces Last Patient Enrolled in Modified JUNIPER Phase 2 Upper Limb Spasticity Trial of DaxibotulinumtoxinA for Injection

Revance Announces Last Patient Enrolled in Modified JUNIPER Phase 2 Upper Limb Spasticity Trial of DaxibotulinumtoxinA for Injection

Yahoo | June 30, 2020

Revance Announces Positive Results in Two Phase 2a Studies of DaxibotulinumtoxinA For Injection for the Treatment of Forehead Lines and Crow’s Feet, Respectively

Revance Announces Positive Results in Two Phase 2a Studies of DaxibotulinumtoxinA For Injection for the Treatment of Forehead Lines and Crow’s Feet

Yahoo | June 30, 2020

Revance Therapeutics (RVNC) Surges: Stock Moves 5.5% Higher

Revance Therapeutics (RVNC) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Yahoo | June 26, 2020

Read More 'RVNC' Stories Here

RVNC Price Returns

1-mo 15.54%
3-mo 57.05%
6-mo 13.73%
1-year 96.66%
3-year 1.52%
5-year -21.25%
YTD 52.31%
2019 -19.37%
2018 -43.69%
2017 72.71%
2016 -39.40%
2015 101.65%

Continue Researching RVNC

Here are a few links from around the web to help you further your research on Revance Therapeutics Inc's stock as an investment opportunity:

Revance Therapeutics Inc (RVNC) Stock Price | Nasdaq
Revance Therapeutics Inc (RVNC) Stock Quote, History and News - Yahoo Finance
Revance Therapeutics Inc (RVNC) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8923 seconds.